Phase 2 clinical trial of 5-azacitidine, valproic acid, and all-trans retinoic acid in patients with high-risk acute myeloid leukemia or myelodysplastic syndrome

Emmanuel Raffoux, Hervé Dombret, Christian Récher et al.|Oncotarget|2010

Cited by 134